Effect of Nalbuphine Versus Fentanyl on Hemdoynamic Effects of Laryngoscopy

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age40-60
SponsorRawalpindi Institute of Cardiology

About this trial

Participants will undergo routine pre-operative evaluation. An intravenous line will be placed in the recovery area. On arrival in the operating room, standard monitoring (blood pressure, heart rate, oxygen saturation, ECG, breathing monitor, and temperature) will be applied. A central venous catheter and an arterial line will be inserted under local anesthesia using sterile technique.

Before anesthesia induction, patients will receive premedication including midazolam and an opioid pain-relief injection given slowly through the vein. General anesthesia will then be induced with etomidate. After adequate sedation, a muscle relaxant (atracurium) will be administered, and the patient will be ventilated with 100% oxygen using a face mask. The breathing tube will then be inserted and correct placement confirmed.

During surgery, anesthesia will be maintained with oxygen, sevoflurane gas, and a continuous atracurium infusion. Hemodynamic parameters such as heart rate and blood pressure will be monitored throughout the peri-intubation and intraoperative period.

Eligibility criteria

Qualifiers

Weighing 40-70kg

ASA III of either sex

Undergoing cardiac surgery with CPB

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Nalbuphine
  • Fentanyl

Treatment groups

98 Participants
are divided into 2 treatment groups